The need for addressing posttraumatic stress disorder (PTSD) among combat veterans
returning from Afghanistan and Iraq is a growing public health concern. Current PTSD …

To review the data with respect to prevalence of metabolic syndrome (MetS) and its
correlates in schizophrenia. For this review, electronic search engines PUBMED …

A meta‐analysis was conducted to explore the risk for cardio‐metabolic abnormalities in
drug naïve, first‐episode and multi‐episode patients with schizophrenia and age‐and …

Background Less than half of patients with major depressive disorder (MDD) respond to
their first antidepressant trial. Our understanding of the underlying mechanisms of selective …

Posttraumatic stress disorder (PTSD) is associated with impaired major domains of
psychology and behavior. Individuals with PTSD also have increased co-morbidity with …

The present study was carried out to determine the dietary habits of patients with
schizophrenia and the influence of these habits on the degree of obesity. The study was …

BackgroundMajor depressive disorder (MDD) is underdiagnosed and undertreated in
schizophrenia, and has been strongly associated with impaired quality of life. AimsTo …

Background People with psychotic disorders fulfilling criteria of a severe and persistent
mental illness (SPMI) display a high risk of somatic comorbidity (SC). Methods ACCESS II is …

This study aimed to evaluate the association of the metabolic syndrome (MS) and its
components with neurocognition among patients with schizophrenia. 121 patients with …

Background: Atypical antipsychotic medications increase the risk of developing metabolic
syndrome (MetS) and cardiovascular diseases in people with schizophrenia. Aim: To …